✦ LIBER ✦

EPA-0418 – Long-term safety and effectiveness of lurasidone in schizophrenia: results of a 22 month, open-label extension study

✍ Scribed by Correll, C.; Cucchiaro, J.; Silva, R.; Hsu, J.; Pikalov, A.; Loebel, A.

Book ID: 125818762
Publisher: Elsevier Science
Year: 2014
Tongue: French
Weight: 67 KB
Volume: 29
Category: Article
ISSN: 0924-9338
DOI: 10.1016/S0924-9338(14)77840-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poster #S245 LONG-TERM SAFETY AND EFFECT

Poster #S245 LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY

✍ Pikalov, Andrei; Correll, Christoph; Cucchiaro, Josephine; Silva, Robert; Hsu, J 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB

The acute and long-term effectiveness of

The acute and long-term effectiveness of amisulpride in patients with schizophrenia: results of a 12-month open-label prospective follow-up study

✍ Yong Min Ahn; Kyu Young Lee; Chul-Eung Kim; Dae-Yeob Kang; Jeong-Ho Seok; Young 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

## Objective To compare the effectiveness of amisulpride in acute (up to 8 weeks) and maintenance (week 8 to 12 months) phases of a 12‐month course of treatment in a heterogeneous group of patients with schizophrenia. ## Methods We conducted a 12‐month, open‐label clinical trial with flexible dos

Poster #197 LONG-TERM TREATMENT WITH LUR

Poster #197 LONG-TERM TREATMENT WITH LURASIDONE IN SCHIZOPHRENIA: RESULTS OF AN 8-WEEK DOUBLE-BLIND ACUTE STUDY FOLLOWED BY A 44-WEEK OPEN-LABEL EXTENSION

✍ Kato, Masaki; Ogasa, Masaaki; Ogo, Hiroki; Ishige, Yoko; Sawabe, Hiroshi; Siu, C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Long-term efficacy of ziprasidone in tre

Long-term efficacy of ziprasidone in treatment-resistant schizophrenia: Results from the 1-year, open-label mozart extension study

✍ E. Sacchetti; A. Galluzzo; F. Romeo; B. Gorini; F. Rappard 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 45 KB

(461) Long-term safety and effectiveness

(461) Long-term safety and effectiveness of once-daily, single-entity, abuse-deterrent hydrocodone in chronic nonmalignant and nonneuropathic pain: results of a long-term open-label study

✍ Lynch, S.; Wen, W.; Taber, L.; Munera, C.; Ripa, S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Long-term efficacy and safety of eslicar

Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy

✍ Peter Halász; Joyce A. Cramer; Danilo Hodoba; Anna Członkowska; Alla Guekht; Joa 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 300 KB